20
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Characterization of measles virus strains causing SSPE: A study of 11 cases

Pages 335-344 | Published online: 10 Jul 2009

References

  • Ayata M, Kimoto T, Hayashi K, Seto T, Murata R, Ogura, H (1998). Nucleotide sequences of the matrix protein gene of subacute sclerosing panencephalitis viruses com-pared with local contemporary isolates from patients with acute measles. Virus Res 54: 107–115.
  • Billeter MA, Cattaneo R (1991). Molecular biology of defective measles virus persisting in the human central nervous system. In The Paramyxaviruses. Kinsbury DW (ed). Plenum Press: New York, pp 323–345.
  • Billeter MA, Cattaneo R, Spielhofer P, Kaelin K, Huber M, Schmid A, Baczko K, ter Meulen V (1994). Generation and properties of measles virus mutations typically as-sociated with subacute sclerosing panencephalitis. Ann NY Acad Sci 724: 367–377.
  • Buckland R, Giraudon P, Wild F (1989). Expression of measles virus nucleoprotein in Escherichia coli: Use of deletion mutants to locate the antigenic sites. I Gen Virol 70: 435–441.
  • Cathomen T, Mrkic B, Spehner D, Drillien R, Naef R, Pavlovic J, Aguzzi A, Billeter MA, Cattaneo R (1998a). A matrix-less measles virus is infectious and elicits ex-tensive cell fusion: Consequences for propagation in the brain. EMBO 117: 3899–3908.
  • Cathomen T, Naim HY, Cattaneo R (1998b). Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. I Virol 2: 1224–1234.
  • Cattaneo R, Schmid A, Spielhofer P, Kaelin K, Baczko K, ter Meulen V, Pardowitz J, Flanagan S, Rima BK, Udem SA, Billeter MA (1989). Mutated and hypermutated genes of persistent measles viruses which cause lethal human brain diseases. Virology 173: 415–425.
  • Connolly JH, Allen IV, Hurwitz LJ, Millar JH (1967). Measles-virus antibody and antigen in subacute scleros-ing panencephalitis. Lancet 11: 542–544.
  • Connolly JH, Allen IV, Hurwitz LJ, Millar JH (1968). Sub-acute sclerosing panencephalitis. Clinical, pathological, epidemiological, and virological findings in three pa-tients. Q J Med 37: 625–644.
  • Fournier P, Brons NH, Berbers GA, Wiesmuller KH, Fleckenstein BT, Schneider F, Jung G, Muller CP (1997). Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fu-sion proteins protect against measles encephalitis. I Gen Virol 78: 1295–1302.
  • Griffin DE (2001). Measles virus. In Fields' Virology. Knipe DM, Howley PM (eds). Lippincott Williams and Wilkins: Philadelphia, Pennsylvania, pp 1401–1441.
  • Hirano A, Ayata M, Wang AH, Wong TC (1993). Functional analysis of matrix proteins expressed from cloned genes of measles virus variants that cause subacute sclerosing panencephalitis reveals a common defect in nucleocap - sid binding. I Virol 67: 1848–1853.
  • Jayawant S, Feyi-Waboso A, Wallace S, Heath J, Leary M, Evans R, Ellis J (2000). Retinitis and dementia in a preg-nant girl: An unusual case. Eur JPaediatr Neurol 4: 177–179.
  • Jin L, Brown DW, Ramsay ME, Rota PA, Bellini WJ (1997). The diversity of measles virus in the United Kingdom, 1992–1995. J. Gen Virol 78: 1287–1294.
  • Jin L, Knowles WA, Rota PA, Bellini WJ, Brown DWG (1998). Genetic and antigenic characterisation of the haemagglutinin protein of measles virus strains recently circulating in the UK. Virus Res 55: 107–113.
  • Jin L, Richards A, Brown DWG (1996). Development of a dual target-PCR for detection and characterization of measles virus in clinical specimens. Mol Cell Probes 10: 191–200.
  • Komase K, Kasaoka T, Yoshikawa Y, Sato TA, Yamanouchi K (1990). Molecular analysis of structural protein genes of the Yamagata-1 strain of defective subacute scleros-ing panencephalitis virus. I. Nucleotide sequence of the nucleoprotein gene. Virus Genes 4: 137–149.
  • Krantic S, Gimenez C, Rabourdin-Combe C (1995). Cell-to-cell contact via measles virus haemagglutinin-CD46 interaction triggers CD46 downregulation. I Gen Virol 76: 2793–2800.
  • Manchester M, Eto DS, Valsamakis A, Liton PB, Fernandez-Munoz R, Rota PA, Bellini WJ, Forthal DN, Oldstone MB (2000). Clinical isolates of measles virus use CD46 as a cellular receptor. I Virol 74: 3967–3974.
  • Marttila J, Ilonen J, Norrby E, Salmi A (1999). Characteriza-tion of T cell epitopes in measles virus nucleoprotein. I Gen Virol 80: 1609–1615.
  • Miller C, Farrington CP, Harbert K (1992). The epidemiol-ogy of subacute sclerosing panencephalitis in England and Wales 1970–1989. Int J Epidemiol 21: 998–1006.
  • Miller E (2002). MMR vaccine: Review of benefits and risks. J Infect 44: 1–6.
  • Muller CP, Schroeder T, Tu R, Brons NH, Jung G, Schneider F, Wiesmuller KH (1993). Analysis of the neutraliz-ing antibody response to the measles virus using syn-thetic peptides of the haemagglutinin protein. Scand I Immunol 38: 463–471.
  • Naim HY, Ehler E, Billeter MA (2000). Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells. EMBO 119: 3576–3585.
  • Nanan R, Carstens C, Kreth HW (1995). Demonstration of virus-specific CD8+ memory T cells in measles-seropositive individuals by in vitro peptide stimulation. Clin Exp Immunol 102: 40–45.
  • Obeid OE, Partidos CD, Steward MW (1993). Identification of helper T cell antigenic sites in mice from the haemag-glutinin glycoprotein of measles virus. I Gen Virol 74: 2549–2557.
  • Obeid OE, Partidos CD, Steward MW (1994). Analysis of the antigenic profile of measles virus haemagglutinin in mice and humans using overlapping synthetic peptides. Virus Res 32: 69–84.
  • Parks CL, Wang HP, Kovacs GR, Vasilakis N, Kowalski J, Nowak RM, Lerch RA, Walpita P, Sidhu MS, Udem SA (2002). Expression of a foreign gene by recombinant canine distemper virus recovered from cloned DNAs. Virus Res 83: 131–147.
  • Rima BK, Earle JA, Baczko K, ter Meulen V, Liebert UG, Carstens C, Carabana J, Caballero M, Celma ML, Fernandez-Munoz R (1997). Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. I Gen Virol 78: 97–106.
  • Rota PA, Bloom AE, Vanchiere JA, Bellini WJ (1994). Evolu-tion of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology 198: 724–730.
  • Saito H, Nakagomi O, Morita M (1995). Molecular identifi-cation of two distinct hemagglutinin types of measles virus by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Mol Cell Probes 9: 1–8.
  • Schadeck EB, Partidos CD, Fooks AR, Obeid OE, Wilkinson GW, Stephenson JR, Steward MW (1999). CTL epitopes identified with a defective recombinant adenovirus ex-pressing measles virus nucleoprotein and evaluation of their protective capacity in mice. Virus Res 65: 75–86.
  • Schmid A, Spielhofer P, Cattaneo R, Baczko K, ter Meulen V, Billeter MA (1992). Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology 188: 910–915.
  • Schneider-Schaulies S, Schneider-Schaulies J,Dunster LM, ter Meulen V (1995). Measles virus gene expression in neural cells. In Measles virus. ter Meulen V, Billeter MA (eds). Springer-Verlag: Berlin, pp 101–116.
  • Schneider-Schaulie s S, ter Meulen V (1999). Pathogenic as-pects of measles virus infections. Arch Virol 15: 139–158.
  • Sidhu MS, Chan J, Kaelin K, Spielhofer P, Radecke F, Schneider H, Masurekar M, Dowling PC, Billeter MA, Udem SA (1995). Rescue of synthetic measles virus minireplicons: Measles genomic termini direct efficient expression and propagation of a reporter gene. Virology 208: 800–807.
  • Sidhu MS, Crowley J, Lowenthal A, Karcher D, Menonna J, Cook S, Udem S, Dowling P (1994). Defective measles virus in human subacute sclerosing panencephalitis brain. Virology 202: 631–641.
  • Sinitsyna OA, Khudaverdyan OE, Steinberg LL, Nagieva FG, Lotte VD, Dorofeeva LV, Rozina EE, Boriskin YuS (1990). Further-attenuated measles vaccine: Virus pas-sages affect viral surface protein expression, immuno-genicity and histopathology pattern in vivo. Res Virol 141: 517–531.
  • Tatsuo H, Ono N, Tanaka K, Yanagi Y (2000). SLAM (CDw150) is a cellular receptor for measles virus. Nature 406: 893–897.
  • Udem SA, Cook KA (1984). Isolation and characterization of measles virus intracellular nucleocapsid RNA. I Virol 49: 57–65.
  • Vardas E, Leary PM, Yeats J, Badrodien W, Kreis S (1999). Case report and molecular analysis of subacute scleros-ing panencephalitis in a South African Child. I Clin Mi-crobiol 37: 775–777.
  • Wakefield AJ (1998). Report: The National Vaccine Infor-mation Center's 1st International Public Conference on Vaccination, Alexandria, Virginia. Mothering 86: 44–51.
  • WHO (2001). Nomenclature for describing the genetic characteristics of wild-type measles viruses (update). WHO/Wkly Epi Rec 76: 241–247.
  • Wild TF, Buckland R (1995). Functional aspects of envelope-associated measles virus proteins. Curr Top Microbiol Immunol 191: 51–64.
  • Woelk CH, Jin L, Holmes EC, Brown DWG (2001). Immune and artificial selection in the haemagglutinin (H) glyco-protein of measles virus. I Gen Virol 82: 2463–2474.
  • Woelk CH, Pybus OG, Jin L, Brown DWG, Holmes EC (2002). Increased positive selection pressure in persis-tent (SSPE) versus acute measles virus Infections. I Gen Viol 83: 1419–1430.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.